SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sylvamo Corporation (SLVM) trades at a trailing P/E of 12.3, forward P/E of 14.6. Trailing earnings yield is 8.13%, forward earnings yield 6.84%. PEG 0.27 (Peter Lynch undervalued ≤1.0). Graham Number is $43.12.
Criteria proven by this page:
- VALUE (88/100, Pass) — P/E is below market average (12.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.27); analyst target implies upside (+23.7%); earnings yield beats bond yields (8.13%).
- PEG Ratio 0.27 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.13% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $53.00 (+23.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
88/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SLVM
Valuation Multiples
P/E (TTM)12.3
Forward P/E14.6
PEG Ratio0.27
Forward PEG0.27
P/B Ratio1.68
P/S Ratio0.49
EV/EBITDA5.6
Per Share Data
EPS (TTM)$3.36
Forward EPS (Est.)$2.93
Book Value / Share$24.59
Revenue / Share$85.30
FCF / Share$1.12
Yields & Fair Value
Earnings Yield8.13%
Forward Earnings Yield6.84%
Dividend Yield4.36%
Graham Number$43.12
SharesGrow IV$333.98 (+679.8%)
Analyst Target$53.00 (+23.7%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
2.6 |
0.00 |
0.00 |
0.27 |
- |
| 2019 |
2.9 |
-0.30 |
0.44 |
0.27 |
- |
| 2020 |
6.5 |
-0.12 |
0.52 |
0.46 |
- |
| 2021 |
3.7 |
0.04 |
6.74 |
0.43 |
- |
| 2022 |
18.1 |
-0.28 |
3.15 |
0.59 |
0.47% |
| 2023 |
8.2 |
0.07 |
2.29 |
0.55 |
2.76% |
| 2024 |
10.8 |
0.49 |
3.83 |
0.86 |
1.91% |
| 2025 |
14.6 |
-0.26 |
2.00 |
0.58 |
3.78% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$9.47 |
$4.12B |
$419M |
10.2% |
| 2019 |
$8.55 |
$4.02B |
$377M |
9.4% |
| 2020 |
$3.85 |
$3.01B |
$170M |
5.6% |
| 2021 |
$7.52 |
$3.5B |
$331M |
9.5% |
| 2022 |
$7.57 |
$3.63B |
$336M |
9.3% |
| 2023 |
$5.93 |
$3.72B |
$253M |
6.8% |
| 2024 |
$7.18 |
$3.77B |
$302M |
8% |
| 2025 |
$3.22 |
$3.35B |
$132M |
3.9% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$3.04 |
$2.84 – $3.13 |
$3.32B |
$3.28B – $3.39B |
3 |
| 2027 |
$5.86 |
$5.54 – $6.09 |
$3.39B |
$3.36B – $3.46B |
3 |
| 2028 |
$6.95 |
$6.85 – $7.14 |
$3.31B |
$3.27B – $3.38B |
1 |
